should all platinum sensitive patients recieve parp inhibitors?
Published 6 years ago • 254 plays • Length 2:31Download video MP4
Download video MP3
Similar videos
-
1:08
should 1l maintenance with parp inhibitors be given to all patients with ovarian cancer?
-
3:45
parp inhibitors for ovarian cancer
-
9:47
can parp inhibitors offer benefit for all patients with platinum-sensitive ovarian cancer?
-
1:38
updates in parp inhibition for ovarian cancer
-
1:53
parp inhibitors: game-changers for ovarian cancer patients?
-
6:51
platinum sensitivity and parp inhibition in ovarian cancer
-
24:53
parp inhibitors in platinum sensitive & platinum resistant ovarian cancers
-
3:47
parp inhibitors for metastatic hormone sensitive prostate cancer
-
3:09
the promising potential of parp inhibitors in ovarian cancer
-
4:31
parp inhibitors and platinum sensitivity or resistance
-
0:57
when is the optimal time to use parp inhibitors in prostate cancer patients?
-
2:39
nova phase iii trial of niraparib in platinum-sensitive ovarian cancer patients
-
6:50
recurrent ovarian cancer: parp inhibitors compared
-
4:06
the promise of parp inhibitors and their emerging role in ovarian cancer
-
0:58
tnbc treatment: platinum-based therapy and parp inhibition
-
1:01
choosing the correct parp inhibitor for prostate cancer
-
6:05
mechanisms of resistance to parp inhibitor or platinum chemotherapy in brca1/2 mutated metastati...
-
1:03:39
precision medicine in ovarian cancer with parp inhibitor therapy and companion diagnostics
-
1:10:07
optimizing the use of parp inhibitors in ovarian cancer